Insider’s Insights / Clinical Trial Registries

Cover of the Insider’s Insight: Clinical Trial Registries
Pages
26
Reading time
About 45 min
Updated
November 2026
Format
PDF, free
Regulatory New edition

Clinical Trial Registries: transparency, excellence and compliance

A practical guide to registering trials, reporting results and keeping your records consistent across every registry your programme touches.

Regulatory affairsDisclosure and transparencyMedical writersClinical operations
  • Written by the specialists who prepare registry entries every week
  • Timelines, comparison tables and a red flags checklist
  • Includes an interview with our Head of Medical Writing

Download your free copy

We will email you the guide straight away.

By signing up, you will also receive new and updated Insider’s Insights by email. You can unsubscribe at any time.

What you will learn

Six things you will be able to do after reading this guide.

  • Meet the deadlines that matter

    Register within 21 days of the first participant and report results within 12 months of primary completion under FDAAA 801.

  • Keep one story across every registry

    How the FDA, EU CTR and CTIS, HRA/MHRA and WHO frameworks differ, and how to stay consistent across all of them.

  • Manage compliance across the whole lifecycle

    Why registration is not a one-off task, from protocol development and amendments to long-term record maintenance.

  • Spot the red flags before inspectors do

    The six discrepancies regulators and auditors look for, from outcome switching to unreported terminated studies.

  • Write lay summaries patients can use

    What effective plain-language summaries require, and how patient representatives can strengthen them.

  • Align registry records with your publications

    How journal editors and reviewers compare registered endpoints with what you publish, and how to keep them matched.

How well do you know your registries?

Three quick questions taken from the guide. Test what you already know.

0of 3 correct so far

Question 1 of 3

Under FDAAA 801, how long do you have to register a trial after the first participant is enrolled?

21 days. Results then follow within 12 months of primary completion. The guide sets out how these deadlines compare across the EU, UK and WHO frameworks.

You scored 0 out of 3

The guide goes into each of these in depth, alongside the rest of what sponsors need to know about registry compliance.

Download the free guide

Look inside

A few of the 26 pages, so you know exactly what you are getting.

Sample page: Key insights
Key insightsTwo checklists to get you started
Sample page: How registries came to be
How registries came to beA timeline from 1997 to today
Sample page: The modern regulatory landscape
The modern regulatory landscapeFDA, EU, UK and WHO side by side
Sample page: The registry lifecycle
The registry lifecycleCompliance from protocol to maintenance
Sample page: Inspection readiness
Inspection readinessThe six red flags auditors look for
“A pragmatic future involves AI-supported transparency governance where technology enhances operational efficiency.”
Justin Cook, Head of Medical Writing, from the interview in this guide

Frequently asked questions

What is a clinical trial registry and why does it matter?

A clinical trial registry is a public database where trials are recorded to address publication bias and selective reporting. Regulators, journals, ethics committees, funders and patients now expect registry information to be accurate, complete and consistent throughout a study's lifecycle.

What are the main regulatory requirements for registry compliance?

Requirements vary by jurisdiction and include FDAAA 801 in the US, the EU Clinical Trials Regulation via CTIS, WHO ICTRP, and HRA/MHRA rules in the UK. Most frameworks mandate registration shortly after first participant enrolment and results reporting within a set timeframe after primary completion.

Why do so many trials fail to report results on time?

Non-compliance is common because organisations often treat registry management as an isolated administrative task rather than an integrated operational discipline. Compliance rates differ significantly between large commercial sponsors and academic or non-industry sponsors, largely due to fragmented governance and limited resources.

How does CTIS change the way sponsors prepare documents?

CTIS operates on a principle of transparency by default, meaning documents submitted during regulatory review may become publicly accessible unless a deferral or redaction applies. This means sponsors must consider public disclosure implications from the earliest stages of protocol drafting.

Can AI fully automate registry compliance?

AI can support repetitive tasks such as deadline monitoring and discrepancy detection, but experienced human oversight remains essential for judgement calls around commercial confidentiality, publication timing and cross jurisdictional obligations. Registry governance still requires scientific and regulatory expertise that technology cannot fully replace.

Part of a reading path

Preparing a regulatory submission

Need support with registry disclosure?

Scientific and Regulatory Writing

Registry entries, results summaries and lay summaries prepared to agency standards.

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility